Reynders McVeigh Capital Management, LLC historic quarter change: Foreign Stocks, Added
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 22 quarters from 2013-06-30 to 2026-03-31, Reynders McVeigh Capital Management, LLC opened 9 positions, added to 54, reduced 48 and sold out of 8.
- Q1 2026: Stock UL; Country of operation —; Class SPONSORED ADR; Shares before 288,396.
- Q1 2026: Stock TSM; Country of operation —; Class SPONSORED ADS; Shares before 3,914.
- Q4 2025: Stock TSM; Country of operation —; Class SPONSORED ADS; Shares before 3,912.
- Q3 2025: Stock ARM; Country of operation —; Class SPONSORED ADR; Shares before 137,598.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1455969), 22 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-27); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-02); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-17); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-09-04); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-12); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-13); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-13); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-07); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-07); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-04); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-10); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-12); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-08); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-09); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-07); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-11); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-12); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-07); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-08). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q1 2026 | UL
Unilever PLC | | SPONSORED ADR | 288,396 | 304,046 | +15,650 | $18,861 | $17,322 | -$1,539 | 2026-04-27 |
|---|
| Q1 2026 | TSM
Taiwan Semiconductor Manufacturing Co., Ltd. | | SPONSORED ADS | 3,914 | 3,964 | +50 | $1,189 | $1,339 | +$150 | 2026-04-27 |
|---|
| Q4 2025 | TSM
Taiwan Semiconductor Manufacturing Co., Ltd. | | SPONSORED ADS | 3,912 | 3,914 | +2 | $1,093 | $1,189 | +$96 | 2026-02-02 |
|---|
| Q3 2025 | ARM
Arm Holdings PLC | | SPONSORED ADR | 137,598 | 138,943 | +1,345 | $22,255 | $19,659 | -$2,596 | 2025-11-17 |
|---|
| Q3 2025 | ULXXXX
Unilever PLC | | SPONSORED ADR | 249,835 | 298,311 | +48,476 | $15,282 | $17,684 | +$2,402 | 2025-11-17 |
|---|
| Q3 2025 | RELX
Relx PLC | | SPONSORED ADR | 621,443 | 665,672 | +44,229 | $33,769 | $31,792 | -$1,977 | 2025-11-17 |
|---|
| Q3 2025 | NVS
Novartis AG | | SPONSORED ADR | 73,657 | 81,871 | +8,214 | $8,913 | $10,499 | +$1,586 | 2025-11-17 |
|---|
| Q2 2025 | ULXXXX
Unilever PLC | | SPONSORED ADR | 77,175 | 249,835 | +172,660 | $4,596 | $15,282 | +$10,686 | 2025-09-04 |
|---|
| Q2 2025 | ARM
Arm Holdings PLC | | SPONSORED ADR | 118,279 | 137,598 | +19,319 | $12,631 | $22,255 | +$9,624 | 2025-09-04 |
|---|
| Q2 2025 | RELX
Relx PLC | | SPONSORED ADR | 611,620 | 621,443 | +9,823 | $30,832 | $33,769 | +$2,937 | 2025-09-04 |
|---|
| Q2 2025 | TSM
Taiwan Semiconductor Manufacturing Co., Ltd. | | SPONSORED ADS | 3,902 | 3,912 | +10 | $648 | $886 | +$238 | 2025-09-04 |
|---|
| Q1 2025 | RELX
Relx PLC | | SPONSORED ADR | 560,733 | 611,620 | +50,887 | $25,469 | $30,832 | +$5,363 | 2025-05-12 |
|---|
| Q1 2025 | ARM
Arm Holdings PLC | | SPONSORED ADR | 90,615 | 118,279 | +27,664 | $11,178 | $12,631 | +$1,453 | 2025-05-12 |
|---|
| Q1 2025 | ULXXXX
Unilever PLC | | SPONSORED ADR | 71,145 | 77,175 | +6,030 | $4,034 | $4,596 | +$562 | 2025-05-12 |
|---|
| Q4 2024 | ARM
Arm Holdings PLC | | SPONSORED ADR | 37,009 | 90,615 | +53,606 | $5,293 | $11,178 | +$5,885 | 2025-02-13 |
|---|
| Q4 2024 | RELX
Relx PLC | | SPONSORED ADR | 495,004 | 560,733 | +65,729 | $23,493 | $25,469 | +$1,976 | 2025-02-13 |
|---|
| Q3 2024 | RELX
Relx PLC | | SPONSORED ADR | 375,599 | 495,004 | +119,405 | $17,232 | $23,493 | +$6,261 | 2024-11-14 |
|---|
| Q3 2024 | TSM
Taiwan Semiconductor Manufacturing Co., Ltd. | | SPONSORED ADS | 4,322 | 4,346 | +24 | $751 | $755 | +$4 | 2024-11-14 |
|---|
| Q2 2024 | RELX
Relx PLC | | SPONSORED ADR | 26,415 | 375,599 | +349,184 | $1,144 | $17,232 | +$16,088 | 2024-08-13 |
|---|
| Q3 2016 | NVS
Novartis AG Sp ADR | | SPONSORED ADR | 308,894 | 309,751 | +857 | $25,487,000 | $24,458,000 | -$1,029,000 | 2016-11-07 |
|---|
| Q3 2016 | TEVA
Teva Pharmaceutical Industries | | ADR | 165,608 | 168,278 | +2,670 | $8,319,000 | $7,742,000 | -$577,000 | 2016-11-07 |
|---|
| Q3 2016 | ULXXXX
Unilever PLC Sp ADR | | SPONSORED ADR | 51,465 | 63,340 | +11,875 | $2,466,000 | $3,002,000 | +$536,000 | 2016-11-07 |
|---|
| Q2 2016 | NVS
Novartis AG Sp ADR | | SPONSORED ADR | 277,537 | 308,894 | +31,357 | $20,105,000 | $25,487,000 | +$5,382,000 | 2016-08-04 |
|---|
| Q2 2016 | ULXXXX
Unilever PLC Sp ADR | | SPONSORED ADR | 38,020 | 51,465 | +13,445 | $1,718,000 | $2,466,000 | +$748,000 | 2016-08-04 |
|---|
| Q2 2016 | TEVA
Teva Pharmaceutical Industries | | ADR | 152,850 | 165,608 | +12,758 | $8,179,000 | $8,319,000 | +$140,000 | 2016-08-04 |
|---|
| Q2 2016 | NVO
Novo-Nordisk AS ADR | | ADR | 38,162 | 40,612 | +2,450 | $2,068,000 | $2,184,000 | +$116,000 | 2016-08-04 |
|---|
| Q1 2016 | NVS
Novartis A G | | SPONSORED ADR | 256,423 | 277,537 | +21,114 | $22,063,000 | $20,105,000 | -$1,958,000 | 2016-05-13 |
|---|
| Q1 2016 | NVO
Novo-Nordisk A S | | ADR | 28,749 | 38,162 | +9,413 | $1,670,000 | $2,068,000 | +$398,000 | 2016-05-13 |
|---|
| Q4 2015 | NVS
Novartis AG Sp ADR | | SPONSORED ADR | 244,002 | 256,423 | +12,421 | $22,429,000 | $22,063,000 | -$366,000 | 2016-02-16 |
|---|
| Q4 2015 | ULXXXX
Unilever PLC Sp ADR | | SPON ADR NEW | 19,020 | 25,495 | +6,475 | $776,000 | $1,099,000 | +$323,000 | 2016-02-16 |
|---|
| Q4 2015 | BP
BP PLC Sp ADR | | SPONSORED ADR | 10,114 | 10,364 | +250 | $309,000 | $324,000 | +$15,000 | 2016-02-16 |
|---|
| Q3 2015 | NVS
NOVARTIS A G | | SPONSORED ADR | 235,973 | 244,002 | +8,029 | $23,206,000 | $22,429,000 | -$777,000 | 2015-11-10 |
|---|
| Q3 2015 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 16,765 | 19,020 | +2,255 | $720,000 | $776,000 | +$56,000 | 2015-11-10 |
|---|
| Q2 2015 | NVS
NOVARTIS A G | | SPONSORED ADR | 227,308 | 235,973 | +8,665 | $22,415,000 | $23,206,000 | +$791,000 | 2015-08-12 |
|---|
| Q2 2015 | NVO
NOVO-NORDISK A S | | ADR | 28,874 | 31,649 | +2,775 | $1,542,000 | $1,733,000 | +$191,000 | 2015-08-12 |
|---|
| Q2 2015 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 12,926 | 16,765 | +3,839 | $539,000 | $720,000 | +$181,000 | 2015-08-12 |
|---|
| Q1 2015 | NVS
NOVARTIS A G | | SPONSORED ADR | 220,366 | 227,308 | +6,942 | $20,419,000 | $22,415,000 | +$1,996,000 | 2015-05-08 |
|---|
| Q1 2015 | NVO
NOVO-NORDISK A S | | ADR | 28,094 | 28,874 | +780 | $1,189,000 | $1,542,000 | +$353,000 | 2015-05-08 |
|---|
| Q1 2015 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 11,951 | 12,926 | +975 | $484,000 | $539,000 | +$55,000 | 2015-05-08 |
|---|
| Q4 2014 | NVO
NOVO-NORDISK A S | | ADR | 27,969 | 28,094 | +125 | $1,332,000 | $1,189,000 | -$143,000 | 2015-02-09 |
|---|
| Q4 2014 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 11,371 | 11,951 | +580 | $476,000 | $484,000 | +$8,000 | 2015-02-09 |
|---|
| Q3 2014 | NVS
NOVARTIS A G | | SPONSORED ADR | 169,166 | 222,280 | +53,114 | $15,315,000 | $20,922,000 | +$5,607,000 | 2014-11-07 |
|---|
| Q3 2014 | SQM
SOCIEDAD QUIMICA MINERA DE C | | SPON ADR SER B | 36,740 | 115,260 | +78,520 | $1,077,000 | $3,013,000 | +$1,936,000 | 2014-11-07 |
|---|
| Q3 2014 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 8,917 | 11,371 | +2,454 | $404,000 | $476,000 | +$72,000 | 2014-11-07 |
|---|
| Q2 2014 | NVS
NOVARTIS A G | | SPONSORED ADR | 167,777 | 169,166 | +1,389 | $14,264,000 | $15,315,000 | +$1,051,000 | 2014-08-11 |
|---|
| Q2 2014 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 7,351 | 8,917 | +1,566 | $314,000 | $404,000 | +$90,000 | 2014-08-11 |
|---|
| Q2 2014 | BP
BP PLC | | SPONSORED ADR | 12,954 | 13,118 | +164 | $623,000 | $692,000 | +$69,000 | 2014-08-11 |
|---|
| Q2 2014 | SQM
SOCIEDAD QUIMICA MINERA DE C | | SPON ADR SER B | 35,260 | 36,740 | +1,480 | $1,119,000 | $1,077,000 | -$42,000 | 2014-08-11 |
|---|
| Q1 2014 | NVS
NOVARTIS A G | | SPONSORED ADR | 163,637 | 167,777 | +4,140 | $13,153,000 | $14,264,000 | +$1,111,000 | 2014-05-12 |
|---|
| Q1 2014 | SQM
SOCIEDAD QUIMICA MINERA DE C | | SPON ADR SER B | 23,000 | 35,260 | +12,260 | $595,000 | $1,119,000 | +$524,000 | 2014-05-12 |
|---|
| Q1 2014 | NVO
NOVO-NORDISK A S | | ADR | 7,782 | 38,340 | +30,558 | $1,438,000 | $1,750,000 | +$312,000 | 2014-05-12 |
|---|
| Q4 2013 | NVS
NOVARTIS A G | | SPONSORED ADR | 161,717 | 163,637 | +1,920 | $12,405,000 | $13,153,000 | +$748,000 | 2014-02-07 |
|---|
| Q4 2013 | SQM
SOCIEDAD QUIMICA MINERA DE C | | SPON ADR SER B | 10,100 | 23,000 | +12,900 | $309,000 | $595,000 | +$286,000 | 2014-02-07 |
|---|
| Q3 2013 | NVS
NOVARTIS A G | | SPONSORED ADR | 159,997 | 161,717 | +1,720 | $11,313,000 | $12,405,000 | +$1,092,000 | 2013-11-08 |
|---|